• <em>In vitro</em> characterization of rare anti-α_IIbβ₃ isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets vi
• A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinoma
• A lethal case of massive hemorrhage after percutaneous liver biopsy in a patient with thrombasthenia
• A novel ITGA2B double cytosine frameshift variant (c.1986_1987insCC) leads to Glanzmann's thrombasthenia in a cat
• A novel LAD-III mutation manifests functional importance of the compact FERM domain in Kindlin-3
• A novel leukocyte adhesion deficiency type III mutation manifests functional importance of the compact FERM domain in kindlin-3
• A single F153Sbeta3 mutation causes constitutive integrin alphaIIbbeta3 activation in a variant form of Glanzmann thrombasthenia
• A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia
• A Trp11Arg Substitution in the beta3 Signal Peptide Prevents Expression of alphaIIbbeta3 in Patients with Glanzmann Thrombasthenia
• A Trp11Arg Substitution in the β3 Signal Peptide Prevents Expression of αIIbβ3 in Patients with Glanzmann Thrombasthenia
• Acquired Glanzmann's thrombasthenia with IgG and IgA against activated alpha(IIb) beta(3)
• Acquired Glanzmann's thrombasthenia with IgG and IgA against activated α_IIb β₃
• Activated Platelets Upregulate β₂ Integrin Mac-1 (CD11b/CD18) on Dendritic Cells, Which Mediates Heterotypic Cell-Cell Interaction
• Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow
• Anti-platelet treatment challenges in Glanzmann thrombasthenia-clinical practice when data lacks
• Apixaban for treatment of venous thromboembolism in an obese patient with Glanzmann thrombasthenia
• Association of autosomal-recessive-type distal renal tubular acidosis and Glanzmann thrombasthenia as a consequence of runs of homozygosity
• Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC
• Bleeding disorders in Saudi Arabia, causes and prevalence: a review
• Catheter Intervention in a Patient with Intracranial Aneurysms and Glanzmann Thrombasthenia Caused by a Novel Homozygous Likely Pathogenic Variant in the ITGA2B Gene
• Clinical Characteristics and Molecular Genetic Analysis of a Pedigree with Glanzmann's Thrombasthenia
• Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders
• Description and Clinical Management of Patients With Glanzmann's Thrombasthenia in a University Hospital, a Referral Center Specialized in Hemostasis, in Bogota, Colombia
• Detection of alloimmunization in Glanzmann Thrombasthenia and Bernard-Soulier Syndrome: Data from a Brazilian Center
• Diagnostic workup of inherited platelet disorders
• Double jeopardy, glomangiopericytoma and Glanzmann thrombasthenia resulting in recurrent epistaxis: a case report
• Effect of c.1431C &gt; T mutation, a causative mutation of Glanzmann's thrombasthenia, on ITGB3 splicing, gene and protein expression
• Effect of c.1431C > T mutation, a causative mutation of Glanzmann's thrombasthenia, on ITGB3 splicing, gene and protein expression
• Effect of c.1431C&gt;T mutation, a causative mutation of Glanzmann's thrombasthenia, on ITGB3 splicing, gene and protein expression
• Effects of the ITGA2B Nonsense Mutation (c.2659C > T, p.Q887X) on Platelet Function in a Mouse Model of Glanzmann's Thrombasthenia Generated with CRISPR/Cas9 Technology
• Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia
• Elevated CD9 expression as a potential biomarker for diagnosis of Bernard-Soulier syndrome
• Emergency cesarean section in glanzmann thrombasthenia: Anaesthetic management without recombinant factor VIIa
• Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders
• Excellent Outcome Following Sibling Peripheral Blood Hematopoietic Stem Cell Transplantation for Glanzmann Thrombasthenia: A Case Report
• Expert opinion on the use of platelet secretion assay for the diagnosis of inherited platelet function disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology
• Fibrin glue in managing intractable gingival bleeding in patients with inherited bleeding disorders-a quasi-experimental pilot study
• Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value
• Frequency, clinical, and laboratory findings of platelet secretion disorders in patients referred to the specialized coagulation laboratory of the Iranian Blood Transfusion Organization
• Glanzmann Thrombasthenia
• Glanzmann Thrombasthenia
• Glanzmann Thrombasthenia 10 Years Later: Progress Made and Future Directions
• Glanzmann Thrombasthenia Associated with Siderotic Synovitis and Arthropathy: A Case Report
• Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor alphaIIbbeta3
• Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3
• Glanzmann thrombasthenia: an uncommon cause of acute upper gastrointestinal bleeding
• Glanzmann thrombasthenia: Use of hemocoagulase (BotroClot) for arrest of bleeding during a primary tooth endodontic procedure
• Glanzmann's thrombasthenia associated with gastrointestinal angiodysplasias successfully treated with bevacizumab
• Glanzmann's thrombasthenia during pregnancy complicated by large subchorionic hematoma managed with antifibrinolytics, human leukocyte antigen-matched platelet transfusion, and primary cesarean delivery: a case report
• Glanzmann's thrombasthenia: A nightmare for hernia surgeons
• Hemorrhage of Upper Digestive and Respiratory Tracts in a Child with Glanzmann Thrombasthenia
• High Rates of Anti-alphaIIbbeta3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration
• High Rates of Anti-αIIbβ3 Antibodies Produced by a Glanzmann Thrombasthenia Patient after First and Unique Red Blood Cells Administration
• How I manage pregnancy in women with Glanzmann thrombasthenia
• Human sphingomyelin synthase 1 generates diacylglycerol in the presence and absence of ceramide via multiple enzymatic activities
• Immune gene polymorphisms associated with poor response to platelet transfusion and recombinant factor VII administration in Glanzmann thrombasthenia
• Importance of Skin Lesions in the Early Diagnosis of Glanzmann Trombasthenia: A Case Report
• In vitro characterization of rare anti-alpha(IIb)beta(3) isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets via complement activation
• Integrin-Dependent Transient Density Increase in Detergent-Resistant Membrane Rafts in Platelets Activated by Thrombin
• Iron deficiency anemia and bleeding management in pediatric patients with Bernard-Soulier syndrome and Glanzmann Thrombasthenia: A single-institution analysis
• ISTH bleeding assessment tool and platelet function analyzer in children with mild inherited platelet function disorders
• Molecular dynamics simulations corroborate recombinant expression studies carried out on three alphaIIb beta-propeller mutations reported in Indian Glanzmann thrombasthenia patients
• Molecular dynamics simulations corroborate recombinant expression studies carried out on three αIIb β-propeller mutations reported in Indian Glanzmann thrombasthenia patients
• Monozygotic twin cases of endometriosis with Glanzmann thrombasthenia: a case report and review of literature
• Multicolor flow cytometry in clinical samples for platelet signaling assessment
• Multidisciplinary management of a pregnancy complicated by Glanzmann thrombasthenia: A case report
• Novel homozygous silent mutation of <em>ITGB3</em> gene caused Glanzmann thrombasthenia
• Novel homozygous silent mutation of ITGB3 gene caused Glanzmann thrombasthenia
• Novel RASGRP2 variants in platelet function defects: Indian study
• Novel variants for Glanzmann thrombasthenia manifesting with purpura at birth
• Oral surgery in people with inherited bleeding disorder: A retrospective study
• Patient with a history of Glanzmann thrombasthenia presented with chronic subdural hematoma: a case report study
• Pedigree Analysis and Molecular Mechanism Study of Hereditary Glanzmann Thrombasthenia Caused by Compound Heterozygous Mutation of the ITGA2B Gene
• Pregnancy and childbirth in patients with Glanzmann Thrombasthenia
• Pregnancy and Delivery Management With Recombinant Factor VIIa in a Glanzmann Thrombasthenia Patient: A Case Report
• Prevalence of hemorrhagic ovarian cysts in patients with rare inherited bleeding disorders
• Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age
• Risk factors for future bleeding in patients with mild bleeding disorders: longitudinal data from the Vienna Bleeding Biobank
• Should HLA and HPA-matched platelet transfusions for patients with Glanzmann Thrombasthenia or Bernard-Soulier syndrome be standardized care? A Dutch survey and recommendations
• SINE-VNTR-Alu retrotransposon insertion as a novel mutational event underlying Glanzmann thrombasthenia
• Spectrum of Inherited Bleeding Disorder with Special Reference to von Willebrand Disease in Eastern India
• Stability and utility of flow cytometric platelet activation tests: A modality to bridge the gap between diagnostic demand and supply
• Stem Cell Transplantation in Glanzmann's Thrombasthenia: A Report of Two Adult Patients
• Successful Desensitization Protocol in an Infant Following Anaphylaxis Secondary to Recombinant Factor VIIa
• Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
• Targeting Tissue Factor Pathway Inhibitor with concizumab to improve haemostasis in patients with Glanzmann thrombasthenia: an in vitro study
• Targeting tissue factor pathway inhibitor with concizumab to improve hemostasis in patients with Glanzmann thrombasthenia: an in vitro study
• The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status
• The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
• The necessity of repeat testing for von Willebrand disease in adult patients with mild to moderate bleeding disorders
• Thromboelastography with platelet mapping to guide anesthetic management of emergency cesarean delivery in a patient with thrombasthenia: a case report
• Treatment of spontaneous tonsillar haemorrhage and recurrent profuse epistaxis due to Glanzmanns thrombasthenia: a case report
• Twins With an Identical Novel Mutation in <em>ITGB3</em>: A Case Report of Glanzmann Thrombasthenia-like Syndrome
• Twins With an Identical Novel Mutation in ITGB3: A Case Report of Glanzmann Thrombasthenia-like Syndrome
• Two case reports of Glanzmann thrombasthenia with intracranial hemorrhage and a review of the literature
• Unexplained bruising in an infant: Glanzmann thrombasthenia
• Use of total thrombus-formation analysis system in detecting acquired platelet function defects: A case report
• Utility of the international society on thrombosis and hemostasis-bleeding assessment tool in the diagnosis of patients who suspected of platelet function disorders
• Utility of the ISTH bleeding assessment tool (BAT) in diagnosis of Glanzmann Thrombasthenia patients
• When Glanzmann thrombasthenia encounters antithrombin deficiency: how do we balance the risk and benefit of antithrombotic therapy?